Dr. Sophie Lanzkron, MD

Dr. Lanzkron practices at Jefferson University Physicians in Philadelphia, Pennsylvania.

Dr. Lanzkron's NPI, 1740228444, was assigned on June 3, 2006. Dr. Lanzkron graduated from Albert Einstein College of Medicine in 1991. Dr. Lanzkron holds Maryland license D45858.

Dr. Lanzkron's primary practice is Jefferson University Physicians, at 1015-19 Chestnut St, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-0800.

Dr. Lanzkron's primary practice is Jefferson University Physicians in Philadelphia, Pennsylvania. Dr. Lanzkron is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Lanzkron to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lanzkron practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lanzkron's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lanzkron is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lanzkron's licenses on file in 3 states: Maryland, Pennsylvania and Texas.

Dmand AI lists anemia and chronic leukemia among the conditions Dr. Lanzkron treats.

CMS data shows 24 Medicare services from Dr. Lanzkron across 2 procedure codes in 2024, for 53 Medicare patients. Medicare paid $2,457 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Lanzkron in 2024. The largest group is under 65, with 28 patients. 75% of them have high blood pressure, and 57% have chronic kidney disease. 49% are also on Medicaid. Their average risk score is 4.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lanzkron's median patient age at 42, with 54% women.

In 2024, Dr. Lanzkron wrote 29 Medicare Part D claims for 13 patients. 72% of them were for generic drugs. They cover 3 drugs, with $132,837 in total drug cost. In 2019, CMS named 102 claims across 5 drugs.

Dr. Lanzkron accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lanzkron as offering telehealth.

Dmand AI links 163 papers to Dr. Lanzkron, published from 2008 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Anemia, Sickle Cell, Pain and Hydroxyurea. Dr. Lanzkron has published most often in Am J Hematol. Dr. Lanzkron's most frequent co-authors are Lydia Pecker, MD, John Joseph Strouse, MD and Rakhi Naik, MD.

Dmand AI links Dr. Lanzkron to 9 clinical trials, 4 of them phase 2 studies. Conditions studied include Anemia, Sickle Cell, Anemia, Hemolytic, Congenital and Chronic Pain. Johns Hopkins University sponsors the most, 3. Open Payments lists research payments to Dr. Lanzkron that name 1 trial.

CMS Open Payments shows 27 general payments to Dr. Lanzkron from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Novartis Pharmaceuticals Corporation paid the most, $15,000. It also lists 14 research payments totaling $13,314 from 2020 to 2025, naming 1 clinical trial.

Dr. Lanzkron graduated from Albert Einstein College of Medicine in 1991.

Dr. Lanzkron is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.